The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment

被引：0
|
作者：
Gregory B Melikyan
Emily J Platt
David Kabat
机构：
[1] University of Maryland School of Medicine,Institute of Human Virology
[2] Oregon Health and Science,Department of Biochemistry and Molecular Biology
[3] University,undefined
来源：
Retrovirology | / 4卷
关键词：
Ternary Complex; Adaptive Mutation; Activation Energy Barrier; Monomeric Gp120; Sulfated Peptide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] CCR5 cell surface density and HIV-1 envelope sequences govern antiretroviral potency of CCR5 antagonists
    Miller, MD
    Lineberger, JE
    Dornadula, G
    Danzeisen, RC
    Blau, CR
    Danovich, RM
    Miller, MA
    Finke, PE
    Oates, BD
    Caldwell, CG
    Chen, P
    Meurer, LC
    Mills, SG
    Springer, MS
    Petropoulos, CJ
    Whitcomb, J
    Huang, W
    Fransen, S
    Simon, AJ
    Hazuda, DJ
    ANTIVIRAL THERAPY, 2003, 8 (03) : U66 - U67
  • [22] Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry
    Nahabedian, John
    Sharma, Amit
    Kaczmarek, Maryska E.
    Wilkerson, Greg K.
    Sawyer, Sara L.
    Overbaugh, Julie
    VIROLOGY, 2017, 512 : 180 - 186
  • [23] Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients
    Soulie, Cathia
    Malet, Isabelle
    Lambert-Niclot, Sidonie
    Tubiana, Roland
    Thevenin, Monique
    Simon, Anne
    Murphy, Robert
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    AIDS, 2008, 22 (16) : 2212 - 2214
  • [24] Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists
    Henrich, Timothy J.
    Lewine, Nicolas R. P.
    Lee, Sun-Hee
    Rao, Suhas S. P.
    Berro, Reem
    Gulick, Roy M.
    Moore, John P.
    Tsibris, Athe M. N.
    Kuritzkes, Daniel R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 1931 - 1935
  • [25] Constrained use of CCR5 on CD4+lymphocytes by R5X4 HIV-1: Efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry
    Loftin, Lamorris M.
    Kienzle, Martha F.
    Yi, Yanjie
    Lee, Benhur
    Lee, Fang-Hua
    Gray, Lachlan
    Gorry, Paul R.
    Collman, Ronald G.
    VIROLOGY, 2010, 402 (01) : 135 - 148
  • [26] Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
    Berro, Reem
    Sanders, Rogier W.
    Lu, Min
    Klasse, Per J.
    Moore, John P.
    PLOS PATHOGENS, 2009, 5 (08)
  • [27] Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine
    Kessler, Naama
    Akabayov, Sabine R.
    Moseri, Adi
    Cohen, Leah S.
    Sakhapov, Damir
    Bolton, David
    Fridman, Brandon
    Kay, Lewis E.
    Naider, Fred
    Anglister, Jacob
    FEBS JOURNAL, 2021, 288 (05) : 1648 - 1663
  • [28] Binding Thermodynamics of the N-Terminal Peptide of the CCR5 Coreceptor to HIV-1 Envelope Glycoprotein gp120
    Brower, Evan T.
    Schon, Arne
    Klein, Jeffrey C.
    Freire, Ernesto
    BIOCHEMISTRY, 2009, 48 (04) : 779 - 785
  • [29] Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation
    Polo, S
    Nardese, V
    De Santis, C
    Arcelloni, C
    Paroni, R
    Sironi, F
    Verani, A
    Rizzi, M
    Bolognesi, M
    Lusso, P
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (11) : 3190 - 3198
  • [30] A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5
    Tilton, John C.
    Wilen, Craig B.
    Didigu, Chukwuka A.
    Sinha, Rohini
    Harrison, Jessamina E.
    Agrawal-Gamse, Caroline
    Henning, Elizabeth A.
    Bushman, Frederick D.
    Martin, Jeffrey N.
    Deeks, Steven G.
    Doms, Robert W.
    JOURNAL OF VIROLOGY, 2010, 84 (20) : 10863 - 10876
12345